Handelsinvest Investeringsforvaltning’s Acceleron Pharma XLRN Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-22,000	Closed	-$3.79M	–	122
2021 Q3	$3.79M	Hold	22,000	–	–	0.41%	85
2021 Q2	$2.76M	Hold	22,000	–	–	0.31%	104
2021 Q1	$2.98M	Hold	22,000	–	–	0.36%	99
2020 Q4	$2.81M	Buy	22,000 +7,000	+47%	+$821K	0.42%	81
2020 Q3	$1.69M	Buy	+15,000	New	+$1.49M	0.32%	82

Handelsinvest Investeringsforvaltning's XLRN Position: Q4 2021 in Review

Handelsinvest Investeringsforvaltning sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 22,000 shares — an estimated $3.79M sold.

Handelsinvest Investeringsforvaltning first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $3.79M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Handelsinvest Investeringsforvaltning reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Handelsinvest Investeringsforvaltning sold 22,000 Acceleron Pharma shares in Q4 2021, an estimated $3.79M.
Handelsinvest Investeringsforvaltning first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
Handelsinvest Investeringsforvaltning's Acceleron Pharma position peaked at $3.79M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q4 2021, filed 7 Feb 2022.